Morgan Stanley Starts Pharmacyclics (PCYC) at Equalweight
Tweet Send to a FriendGet Alerts PCYC Hot Sheet
Price: $84.89 +1.16%
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
8 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade PCYC Now!
Morgan Stanley initiates coverage on Pharmacyclics (NASDAQ: PCYC) with a Equalweight.
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $86.62 yesterday, with a 52 week range of $24.50-$95.85.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Pharmacyclics click here. For more ratings news on Pharmacyclics click here.
Shares of Pharmacyclics closed at $86.62 yesterday, with a 52 week range of $24.50-$95.85.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- UBS Starts Regeneron Pharma (REGN) at Neutral
- Jefferies Starts Cempra, Inc. (CEMP) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
